Board Meeting23 Oct 2026, 04:40 pm
Advanced Enzyme Technologies Board Meeting on Oct 31 for Q2 FY27 Results
AI Summary
Advanced Enzyme Technologies Ltd has announced that its Board of Directors will convene on October 31, 2026. The primary agenda item is to consider and approve the un-audited financial results for both standalone and consolidated operations for the quarter and half-year ended September 30, 2026. Concurrently, the trading window for company securities will remain closed until November 02, 2026, as previously intimated.
Key Highlights
- Board meeting scheduled for October 31, 2026.
- To approve un-audited financial results for Q2 FY27.
- Results will be considered on standalone and consolidated basis.
- Trading window to remain closed until November 02, 2026.
Price Impact
More from ADVENZYMES